In Brief: Wright Medical
This article was originally published in The Gray Sheet
Executive Summary
Wright Medical: Introduces the PDA Calcar Hip Replacement System, designed to "address fracture and revision surgeries where proximal bone loss has occurred and enhanced implant stability" is needed. The Calcar system rounds out the low-end PDA (Patient Demand Alternative) line acquired by Arlington, Tennessee-based Wright through its purchase of Orthomet last year. The system includes "four implant sizes with proportional stem lengths and two Calcar replacement levels to address a wide range of surgical requirements." The implants, made of forged cobalt chrome, can be used with Wright Medical's Orthoset bone cement products," Wright notes...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.